OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure

PHASE3TerminatedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

February 12, 2016

Primary Completion Date

January 15, 2021

Study Completion Date

January 15, 2021

Conditions
Non Small Cell Lung Cancer
Interventions
BIOLOGICAL

OSE2101

DRUG

Docetaxel

DRUG

Pemetrexed

Trial Locations (78)

119

IRCCS Regina Elena National Cancer Institute, Roma

1062

Magyar Honvedseg Egeszsegugyi Kozpont II szamu telephely, Budapest

1121

Országos Korányi TBC és Pulmonológiai Intézet XI Tüdőbelosztály, Budapest

Országos Korányi TBC és Pulmonológiai Intézet XIV Tüdőbelosztály, Budapest

1125

Semmelweis Egyetem Altalanos Orvostudományi Kar Pulmonologiai Klinika, Budapest

3233

Matrai Gyogyintézet, Mátraháza

6772

Csongrad Megyei Mellkasi Betegsegek Szakkorháza I Tüdőosztály, Deszk

10003

Centre Hospitalier Troyes, Troyes

12808

Všeobecná Fakultní nemocnice, Prague

13273

Paoli-Calmettes Institute, Marseille

15006

"Complejo Hospitalario Universitario A Coruna (CHUAC)", A Coruña

17822

Gesinger Medical Center, Danville

20007

Georgetown University Hospital, Washington D.C.

28046

Hospital Universitario La Paz Servicio de Oncología Médica, Madrid

28220

Hospital Universitario Puerta de Hierro Majadahonda Servicio de Oncología Médica Consultas externas, 2ª planta, Madrid

29010

Hospital Universitario Carlos Haya, Málaga

29200

CHGU Morvan - Brest, Brest

31059

Hôpital Larrey - CHU de Toulouse, Toulouse

33076

Institut Bergonié, Bordeaux

33322

BRCR Medical Center, Inc, Boca Raton

34295

CHU Montpellier, Montpellier

35128

Istituto Oncologico Veneto, IRCCS, Padua

37044

Centre Hospitalier Régional Universitaire de Tours, Tours

37045

Oncologia medica, Legnano

37126

Ospedale Civile Maggiore, Verona

38043

CHU Grenoble, Grenoble

44277

Centre Catherine de Sienne, Nantes

44281

Meir Medical Center, Kfar Saba

44718

Gabrail Cancer Center Research, Canton

47014

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T), Meldola

47923

U.O. Oncologia Ospedale Infermi, Rimini

49300

Centre Hospitalier de Cholet, Cholet

51109

Krankenhaus Mehrheit - Kliniken der Stadt Köln - Lungenklinik, Cologne

53100

Policlinico Santa Maria alle Scotte, Siena

56124

Azienda USL 2 Lucca - Dipartimento Oncologico, Lucca

58633

Nemocnice Jihlava, Onkologické oddelení, Jihlava

59000

Hopital Albert Calmette, Lille

67091

CHU de Strasbourg - Hôpital Civil, Strasbourg

68100

Hôpital Emile Muller, Mulhouse

69500

Hôpital Louis Pradel, Bron

70124

IRCCS Oncologico Giovanni Paolo II, Bari

70433

Pontchartrain Cancer Center, Covington

72000

Clinique Victor Hugo, Le Mans

72037

Centre Hospitalier du Mans, Le Mans

72076

Universitätsklinikum Tübingen Medizinische Klinik II, Tübingen

73100

Unità Operativa di Oncologia dell'Ospedale Vito Fazzi di Lecce, Piazza Muratore, Lecce

73104

Stephenson Cancer Center, Oklahoma City

75010

Hôpital Saint-Louis, Paris

75018

Hôpital Bichat - Claude-Bernard, Paris

75970

Hôpital Tenon, Paris

77090

Millenium Oncology, Houston

80131

U.O.C. Pneumologia a indirizzo oncologico, Presidio Ospedaliero Monaldi - Azienda Ospedaliera dei Colli - Via Leonardo Bianchi, Napoli

84101

Soroka University Medical Center, Beersheba

84918

Institut Saint Catherine, Avignon

89081

Klinik für Innere Medizin II Universitätsklinikum Ulm, Ulm

91505

East Valley Hematology and Oncology medical Group, Burbank

93000

Hôpital Avicenne, Bobigny

94010

Hôpital intercommunal de Créteil, Créteil

94160

Hôpital d'Instruction des Armées Bégin, Saint-Mandé

94805

Institut Gustave Roussy (IGR), Villejuif

97225

Robert W. Franz Cancer Center, Portland

100001

Meyer Cancer Center, Weill Cornell Medecine, New York

3109601

Rambam Health Care Campus, Haifa

4941492

Rabin (Belinson) Medical Center, Petah Tikva

9087200

Hadassah Campus Ein Kerem, Jerusalem

06120

Klinik für Innere Medizin II Hospital Martha-Maria Halle-Dölau gGmbH, Halle

06126

Ospedale di Perugia - Oncologia medica, Perugia

00128

UOC di Oncologia Medica, Policlinico Universitario Campus Biomedico, Roma

80-952

Klinika Onkologii i Radioterapii , Uniwersyteckie Centrum Kliniczne, Gdansk

62-500

"Przychodnia Lekarska KOMED", Konin

Unknown

Mazowieckie Centrum Leczenia chorób Płuc i Gruźlicy, Otwock

87-100

Wojewódzki Szpital Zespolony , Oddział Chemioterapii Nowotworów, Torun

08028

Hospital Universitari Quirón Dexeus, Barcelona

08035

Hospital Universitari Vall D'Hebron, Barcelona

08304

Hospital de Mataro, Barcelona

Hospital de Mataro, Mataró

08916

Hospital Universitario Germans Trias i Pujol, Barcelona

MK6 5LD

Milton Keynes Hospital, Milton Keynes

Sponsors
All Listed Sponsors
lead

OSE Immunotherapeutics

INDUSTRY

NCT02654587 - OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure | Biotech Hunter | Biotech Hunter